Nektar to Announce Financial Results for the Third Quarter 2024 on Thursday, November 7, 2024, After Close of U.S.-Based Financial Markets
1. Nektar Therapeutics will announce Q3 2024 results on November 7. 2. CEO Howard Robin will host a conference call at 5 PM ET. 3. Focused on immunological treatments with key clinical trials ongoing. 4. Lead candidate REZPEG is in Phase 2b trials for specific diseases.